(2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid

1 trials 1 recruiting VVarious

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase III

Phase III: 1

Oversight events:

2 serious breaches across 1 trial

Indications tested

1 total

[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer Recruiting

2023-504026-19-01 Phase III 5 countries Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH

Showing 1–1 of 1 trials